Loading organizations...
§ Private Profile · Redmond, WA, USA
Medical device developer offering AI-powered handheld point-of-care ultrasound devices for clinicians, enabling accurate bedside diagnostics.
Based in Redmond, Washington, EchoNous develops artificial intelligence powered handheld point of care ultrasound devices designed for hospitals and clinical healthcare providers. The company's flagship Kosmos platform provides miniaturized diagnostic imaging hardware equipped with machine learning guided image acquisition, advanced cardiac analysis, and Doppler capabilities to facilitate accurate bedside clinical assessments. Operating with a current workforce of 73 employees, the enterprise successfully secured FDA approval for its core diagnostic platform in 2020 and subsequently expanded its software compatibility across both Google Android and Apple iOS mobile operating systems. EchoNous is financially backed by the global alternative investment firm KKR, operating under an executive leadership team that currently includes Chief Executive Officer Graham Cox alongside board Chairman Doug Logigian. The medical technology company was originally founded in 2016 by healthcare industry veterans Kevin Goodwin and Dr. Niko Pagoulatos.
EchoNous has raised $159.0M across 4 funding rounds.
EchoNous has raised $159.0M in total across 4 funding rounds.
EchoNous has raised $159.0M across 4 funding rounds. Most recently, it raised $7.0M Other Equity in July 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 13, 2023 | $7M Venture Round | Kennedy Lewis Investment Management | — | Announced |
| Sep 28, 2022 | $57M Series D | Kennedy Lewis Investment Management | — | Announced |
| Jul 2, 2021 | $60M Venture Round | Richard Gumer | — | Announced |
| Sep 28, 2017 | $35M Venture Round | Justin Sabet Peyman | — | Announced |
EchoNous has raised $159.0M in total across 4 funding rounds.
EchoNous's investors include Kennedy Lewis Investment Management, Richard Gumer, Justin Sabet-Peyman.